Comments

Syros Pharmaceuticals Insider Trading Activity

SYRSOTCEM
Logo brought to you by Benzinga Data
Trade with Public
Trade with Public
$0.00050
-0.12-99.57%
Last update: Dec 16, 12:29 PM
OverviewNewsEarningsAnalyst Ratings

Insider Trades

Short Interest

Syros Pharmaceuticals Insider Trading Activity | OTC:SYRS | Benzinga

Track the latest Syros Pharmaceuticals insider trading activity. Stay informed on recent buys, sells, and market impact for Syros Pharmaceuticals stock.

What is Insider Activity?

Insider trading activity involves company insiders, such as executives, directors, and employees, engaging in transactions of their own company's stock. Insiders' buy and sell transactions provide valuable insights into their confidence in the company's future performance.

What are Syros Pharmaceuticals Inc Insiders Doing?

Insiders have report no purchases/sales in the last 30 days.

Notable Recent Insider Buys and Sales

There has been no Insider buying or selling in the last 90 days.

Ownership Statistics for Syros Pharmaceuticals Inc

Shares Outstanding
26.810M
Insider Shares Owned
460.162K
Insider Percentage Owned
1.71%
Institutional Shares Held
14.142K
Institutional Percentage Held
0.05%
Dec 04, 2024Nancy Simonian—-37.07K$0.27-$10.02KSELL-90.26%4.00KDec 02View
Nov 27, 2024Nancy Simonian—-134.71K$0.27-$35.74KSELL-76.64%41.07KNov 25View
Nov 20, 2024Kristin StephensCHIEF DEVELOPMENT OFFICER-36.13K$0.22-$7.95KSELL-100.00%0.00Nov 18View
Nov 20, 2024David RothCHIEF MEDICAL OFFICER-12.10K$0.20-$2.38KSELL-100.00%0.00Nov 18View
Nov 20, 2024Gerald QuirkCHIEF LEGAL & COMPLIANCE OFFIC-46.66K$0.22-$10.32KSELL-100.00%0.00Nov 19View
Nov 20, 2024Conley CheePRESIDENT & CEO-134.80K$0.20-$26.93KSELL-100.00%0.00Nov 18View
Nov 20, 2024Jason HaasCHIEF FINANCIAL OFFICER-137.80K$0.21-$28.98KSELL-100.00%0.00Nov 18View
Sep 12, 2024Conley CheePRESIDENT & CEO100.00K$1.61$160.68KBUY444.37%122.50KSep 10 - Sep 11View
Sep 12, 2024Jason HaasCHIEF FINANCIAL OFFICER100.00K$1.61$161.24KBUY407.30%124.55KSep 10 - Sep 12View
Jul 02, 2024Richard Young—-34.84K$5.12-$178.37KSELL-81.32%8.00KJun 28View
Apr 05, 2024David RothCHIEF MEDICAL OFFICER-10.45K$4.95-$51.73KSELL-100.00%0.00Apr 03View
Apr 02, 2024David RothCHIEF MEDICAL OFFICER10.45K$5.12-$24.97KSELL-OPTIONS∞10.45KMar 31 - Apr 02View
Dec 26, 2023Srinivas AkkarajuDIRECTOR904.98K$4.42$4.00MBUY102.36%1.79MDec 21View
Dec 14, 2023David RothCHIEF MEDICAL OFFICER-6.29K$4.95-$31.12KSELL-100.00%0.00Dec 12View
Dec 08, 2023David RothCHIEF MEDICAL OFFICER-6.29K$3.95-$24.83KSELL-50.00%6.29KDec 06View
Aug 02, 2023David RothCHIEF MEDICAL OFFICER-7.35K$3.95-$29.02KSELL-100.00%0.00Jul 31View
Jul 18, 2023Eric OlsonCHIEF SCIENTIFIC OFFICER-689.00$3.50-$2.41KSELL-9.37%6.66KJul 17View
Oct 03, 2022TIMOTHY TYSONDIRECTOR16.93K$6.26$105.96KBUY211.65%24.93KSep 29 - Sep 30View
Jan 06, 2022Eric OlsonCHIEF SCIENTIFIC OFFICER-2.21K$3.47-$7.65KSELL-100.00%0.00Jan 05View
Jul 01, 2021Eric R OlsonCHIEF SCIENTIFIC OFFICER-1.16K$5.55-$6.46KSELL-100.00%0.00Jul 01View
Mar 17, 2021Eric OlsonCHIEF SCIENTIFIC OFFICER0.00$5.24-$30.71KSELL-OPTIONS0.00%0.00Mar 15View
Feb 18, 2021Richard YoungDIRECTOR-3.75K$12.05-$45.19KSELL-1.15%321.71KFeb 16View
Feb 10, 2021Richard YoungDIRECTOR-3.75K$13.04-$48.90KSELL-1.14%325.46KFeb 08View
Nov 18, 2020Richard Young—-5.99K$8.77-$52.56KSELL-1.74%339.21KNov 16 - Nov 17View
Oct 19, 2020Richard Young—-5.67K$8.75-$49.64KSELL-1.66%335.20KOct 19View
Oct 16, 2020Richard Young—-317.00$8.75-$2.77KSELL-0.09%340.87KOct 15View
Sep 16, 2020Richard Young—-5.99K$10.39-$62.24KSELL-1.73%341.19KSep 15View
Aug 19, 2020Eric Olson—0.00$7.00-$188.84KOPTION EXERCISE0.00%0.00Aug 17 - Aug 18View
Aug 19, 2020Richard Young—-5.99K$12.59-$75.41KSELL-1.70%347.18KAug 17View
Aug 19, 2020Srinivas Akkaraju—-159.33K$13.10-$2.09MSELL-11.11%1.27MAug 17 - Aug 18View
Jul 17, 2020Richard Young—-5.99K$11.85-$70.98KSELL-1.67%353.17KJul 15View
Jul 07, 2020Eric R Olson—-1.75K$11.72-$20.54KSELL-100.00%0.00Jul 07View
Jul 06, 2020Srinivas Akkaraju—-4.63K$11.01-$50.97KSELL-0.32%1.43MJul 01View
Jun 25, 2020Srinivas Akkaraju—-154.70K$11.11-$1.72MSELL-9.71%1.44MJun 23 - Jun 25View
Jun 16, 2020Richard Young—-5.99K$8.75-$52.41KSELL-1.64%359.16KJun 15View
May 15, 2020Richard Young—-5.99K$9.22-$55.24KSELL-1.61%365.15KMay 15View
May 13, 2020Mark Alles—10.00K$8.86$88.59KPURCHASE∞10.00KMay 13View
Apr 17, 2020Richard Young—-23.96K$8.75-$209.65KSELL-6.06%371.14KApr 15View
Feb 20, 2020Eric R Olson—-1.45K$7.38-$10.67KSELL-100.00%0.00Feb 18View
Nov 12, 2019Jeremy P SpringhornCHIEF BUSINESS OFFICER20.00K$4.98$99.60KBUY133.33%35.00KNov 11 - Nov 12View
Aug 19, 2019Richard YoungDIRECTOR-25.00K$10.00-$250.00KSELL-5.95%395.10KAug 15 - Aug 16View
Jul 17, 2019ARCH Venture Fund VII LPARCH Venture Partners VII LPARCH Venture Partners VII LLCKEITH CRANDELLCLINTON BYBEEROBERT NELSEN10% OWNER-63.00K$7.77-$489.28KSELL-1.46%4.24MJul 15 - Jul 17View
Apr 11, 2019Srinivas AkkarajuDIRECTOR533.33K$7.50$4.00MBUY50.32%1.59MApr 09View
Mar 14, 2019ARCH Venture Fund VII LPARCH Venture Partners VII LPARCH Venture Partners VII LLCKEITH CRANDELLCLINTON BYBEEROBERT NELSEN10% OWNER-167.50K$7.83-$1.31MSELL-3.75%4.31MMar 12 - Mar 14View
Mar 11, 2019ARCH Venture Fund VII LPARCH Venture Partners VII LPARCH Venture Partners VII LLCKEITH CRANDELLCLINTON BYBEEROBERT NELSEN10% OWNER-164.58K$6.80-$1.12MSELL-3.55%4.47MMar 07 - Mar 11View
Feb 02, 2018Srinivas AkkarajuDIRECTOR209.42K$9.55$2.00MBUY24.62%1.06MJan 31View
Dec 15, 2017Jeremy P SpringhornCHIEF BUSINESS OFFICER15.00K$9.08$136.26KBUY∞15.00KDec 15View
Dec 14, 2017Srinivas AkkarajuDIRECTOR109.77K$9.03$991.56KBUY15.23%830.49KDec 12 - Dec 14View
Oct 23, 2017Colleen E. DeSimonePRINCIPAL ACCOUNTING OFFICER0.00$9.55-$7.16KSELL-OPTIONS0.00%0.00Oct 23View
Aug 16, 2017Richard YoungDIRECTOR-3.28K$22.00-$72.20KSELL-0.78%420.10KAug 14View
Aug 08, 2017Eric OlsonCHIEF SCIENTIFIC OFFICER0.00$12.30-$56.44KSELL-OPTIONS0.00%0.00Aug 07View
Jul 27, 2017Eric OlsonCHIEF SCIENTIFIC OFFICER0.00$11.43-$260.50KSELL-OPTIONS0.00%0.00Jul 25View
Jul 27, 2017Richard YoungDIRECTOR-3.28K$22.09-$72.50KSELL-0.77%423.38KJul 25View
Jul 07, 2016Amir NashatDIRECTOR1.59M$12.50$5.00MBUY∞48.32KJul 06View
Jul 07, 2016Polaris Management Co VII LLCPolaris Partners VII LPPolaris Entrepreneurs Fund VII LP10% OWNER1.59M$12.50$5.00MBUY∞48.32KJul 06View
Jul 07, 2016Flagship Ventures Fund IV LPFlagship Ventures Fund IVRx LPFlagship VentureLabs IV LLCFlagship Ventures Fund IV General Partner LLCNOUBAR AFEYANEDWIN KANIA JR10% OWNER4.59M$12.50$5.00MBUY∞1.13MJul 06View
Jul 07, 2016Redmile Group LLCJeremy Green10% OWNER898.93K$12.50$5.41MBUY∞49.79KJul 06View
Jul 07, 2016Arch Venture Fund VII LPARCH Venture Partners VII LPARCH Venture Partners VII LLCKEITH CRANDELLCLINTON BYBEE10% OWNER4.42M$12.50$5.00MBUY2073.66%4.64MJul 06View
Jul 06, 2016Robert NelsenDIRECTOR4.42M$12.50$5.00MBUY2073.66%4.64MJul 06View
Jul 06, 2016AISLING CAPITAL III LPAisling Capital Partners III LPAisling Capital Partners III LLCSTEVE ELMSANDREW SCHIFFDennis Purcell10% OWNER908.57K$12.50$5.00MBUY∞908.57KJul 06View
Jul 06, 2016James FlynnDeerfield Mgmt LPCO MANAGEMENT DEERFIELDDeerfield Special Situations Fund LPDeerfield Mgmt III LPDeerfield Private Design Fund III LP10% OWNER2.10M$12.50$5.00MBUY∞628.57KJul 06View

FAQ

Q

Is insider trading legal?

A
Insider trading is legal so long as the insiders report those trades to the SEC. Illegal securities trading occurs when the insider is violating a fiduciary duty or fails to report their trades.
Q

What are some examples of market manipulation?

A
Insider trading, pump and dump schemes, front running and wash trades are all examples of market manipulation. Investors who track insider asset movement should think carefully about why these insiders are trading their stocks before moving forward.

Browse insider trades on all stocks.

Connect With Us
instagramlinkedinyoutubeblueskymastodon
About Benzinga
Market Resources
Trading Tools & Education
Ring the Bell
© 2025 Benzinga | All Rights Reserved